LTO1 and cancer: Further investigations into the molecular mechanisms of VP2-induced ORAOV1 reduction and apoptosis will help to elucidate the pathogenesis of viral infection, and shed lights on the development of VP2 recombinant DNA vaccine against IBDV, along with the development of cancer therapy with VP2 of apoptotic effect.